Optimer Pharmaceuticals News
Most Popular Optimer Pharmaceuticals Story
Optimer surges on antibiotic data
Optimer Pharmaceuticals' stock surged on news that the company's anti-infective drug OPT-80 outperformed ViroPharma's Vancocin in a late-stage trial. Vancocin is currently the only approved treatment... Read more...
Latest Headlines
- November 12, 2008
- July 16, 2008
Paid Research Reports
- RNA therapy: the next big thing after monoclonal antibodies?
- Biotech M&A Strategies: Deal assessments, trends and future prospects
- The Dermatology Market Outlook to 2013: Competitive landscape, pipeline analysis and growth opportunities
- Pipeline Insight: Cancer Overview - Breast, Gynecological, Genitourinary - Diverse drugs approaching the market for many tumor t
- Sales Force Effectiveness
